Published in Cancer Res on December 15, 1998
The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol (2007) 6.16
Alternative splicing and disease. Biochim Biophys Acta (2008) 3.47
Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat Struct Mol Biol (2010) 2.30
Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis. Mol Cell Biol (2007) 2.04
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol (2012) 1.88
Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors. Mol Biol Cell (2001) 1.72
Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev (2009) 1.65
Alternative splicing and tumor progression. Curr Genomics (2008) 1.43
SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci (2010) 1.40
Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol Cell Biol (2009) 1.37
RNA recognition motif 2 directs the recruitment of SF2/ASF to nuclear stress bodies. Nucleic Acids Res (2004) 1.13
Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo. J Virol (2000) 1.08
Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer (2010) 1.05
RNA splicing factors regulated by HPV16 during cervical tumour progression. J Pathol (2009) 1.04
Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol (2013) 1.02
The beta-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression. RNA (2008) 1.00
Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing. J Cell Biochem (2012) 0.94
Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer (2002) 0.93
Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro. PLoS One (2012) 0.93
Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells. RNA (2014) 0.90
Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2012) 0.89
Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology. Biomed Res Int (2015) 0.82
Classification between normal and tumor tissues based on the pair-wise gene expression ratio. BMC Cancer (2004) 0.80
Role of pseudoexons and pseudointrons in human cancer. Int J Cell Biol (2013) 0.79
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression. Oncogene (2016) 0.75
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
Start sites of bidirectional DNA synthesis at the human lamin B2 origin. Science (2000) 2.72
A new phage of Bacillus subtilis with infectious DNA having separable strands. J Mol Biol (1968) 2.64
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 2.53
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Fine mapping of a replication origin of human DNA. Proc Natl Acad Sci U S A (1994) 2.44
cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. Nucleic Acids Res (1988) 2.32
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer. Ann Oncol (2014) 2.29
Nucleo-cytoplasmic distribution of human hnRNP proteins: a search for the targeting domains in hnRNP A1. J Cell Sci (1995) 2.27
Coupling of late transcription to viral replication in bacteriophage T4 development. J Mol Biol (1970) 2.24
No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol (1998) 2.18
hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J Mol Biol (1996) 2.04
[The hemodynamics laboratory without cine film. A comparison between the production costs of 35-mm film and the recordable compact disk]. G Ital Cardiol (1998) 2.03
Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol Cell Biol (1984) 1.96
Isolation of an active gene encoding human hnRNP protein A1. Evidence for alternative splicing. J Mol Biol (1989) 1.95
Mammalian single-stranded DNA binding protein UP I is derived from the hnRNP core protein A1. EMBO J (1986) 1.94
Yoga and chemoreflex response to hypoxia and hypercapnia. Lancet (2000) 1.77
Recombinant hnRNP protein A1 and its N-terminal domain show preferential affinity for oligodeoxynucleotides homologous to intron/exon acceptor sites. Nucleic Acids Res (1990) 1.72
Stress-induced nuclear bodies are sites of accumulation of pre-mRNA processing factors. Mol Biol Cell (2001) 1.72
Identification of a Fab interaction footprint site on an icosahedral virus by cryoelectron microscopy and X-ray crystallography. Nature (1992) 1.71
The gene for a novel human lamin maps at a highly transcribed locus of chromosome 19 which replicates at the onset of S-phase. Mol Cell Biol (1992) 1.66
Alternative splicing in the human gene for the core protein A1 generates another hnRNP protein. EMBO J (1990) 1.65
Disseminated human herpesvirus 6 infection in AIDS. Lancet (1993) 1.64
The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism. Bioessays (1996) 1.63
Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity. Nucleic Acids Res (1993) 1.62
The N-terminal domain of human DNA ligase I contains the nuclear localization signal and directs the enzyme to sites of DNA replication. EMBO J (1995) 1.59
Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Eur Heart J (2002) 1.58
Cardiovascular, cerebrovascular, and respiratory changes induced by different types of music in musicians and non-musicians: the importance of silence. Heart (2005) 1.58
Non-contact mapping to guide catheter ablation of untolerated ventricular tachycardia. Eur Heart J (2002) 1.52
A novel hnRNP protein (HAP/SAF-B) enters a subset of hnRNP complexes and relocates in nuclear granules in response to heat shock. J Cell Sci (1999) 1.50
Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli. Antimicrob Agents Chemother (1973) 1.49
Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis. J Infect Dis (1989) 1.48
High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1--associated predominantly sensory polyneuropathy. J Infect Dis (1995) 1.47
Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression. Br J Pharmacol (2009) 1.45
Rifamycins: a general view. Annu Rev Microbiol (1972) 1.44
Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes. Leuk Lymphoma (1996) 1.42
Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica (2000) 1.42
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
[Analysis of changes in repolarization for the differential diagnosis of narrow QRS supraventricular tachycardia and the site of the accessory pathway]. Cardiologia (1996) 1.40
Interaction of hnRNP A1 with snRNPs and pre-mRNAs: evidence for a possible role of A1 RNA annealing activity in the first steps of spliceosome assembly. Nucleic Acids Res (1992) 1.39
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism. Thromb Haemost (2001) 1.39
Acute and chronic efficacy of felodipine in congestive heart failure. Int J Cardiol (1991) 1.39
Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology (2000) 1.39
[Modulation of atrioventricular conduction in patients with atrial fibrillation or flutter. Immediate and long-term results]. Cardiologia (1995) 1.38
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS (1999) 1.36
Slow breathing reduces chemoreflex response to hypoxia and hypercapnia, and increases baroreflex sensitivity. J Hypertens (2001) 1.34
Cell cycle modulation of protein-DNA interactions at a human replication origin. EMBO J (1998) 1.32
Single stranded DNA binding proteins derive from hnRNP proteins by proteolysis in mammalian cells. Nucleic Acids Res (1985) 1.32
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother (1986) 1.31
HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet (1986) 1.31
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Large-scale purification of hnRNP proteins from HeLa cells by affinity chromatography on ssDNA-cellulose. Eur J Biochem (1987) 1.30
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A (2001) 1.29
Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome. J Infect Dis (1985) 1.29
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
Inguino-scrotal hernia of a double district ureter: case report and literature review. Hernia (2005) 1.28
In vivo protein-DNA interactions at human DNA replication origin. Proc Natl Acad Sci U S A (1996) 1.27
Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol (1997) 1.27
Structure and dynamics of hnRNP-labelled nuclear bodies induced by stress treatments. J Cell Sci (2000) 1.25
Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin Exp Immunol (1985) 1.24
Mammalian single-stranded DNA binding proteins and heterogeneous nuclear RNA proteins have common antigenic determinants. Nucleic Acids Res (1985) 1.23
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood (1996) 1.23
The reproducibility of average ambulatory, home, and clinic pressures. Hypertension (1988) 1.21
Functional characterization of the T4 DNA ligase: a new insight into the mechanism of action. Nucleic Acids Res (1997) 1.20
AIDS-defining diseases in 250 HIV-infected patients; a comparative study of clinical and autopsy diagnoses. AIDS (1992) 1.20
A human DNA replication origin: localization and transcriptional characterization. Chromosoma (1992) 1.19
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors. Antimicrob Agents Chemother (2000) 1.17
The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence (TGACGTCA) is reduced by the misincorporation of U and increased by the deamination of C. Nucleic Acids Res (1990) 1.16
Relationship between competence for transfection and for transformation. J Virol (1968) 1.16
Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med (1992) 1.16
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals. Antivir Ther (2000) 1.16
Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Ann Oncol (2009) 1.14
The replication factory targeting sequence/PCNA-binding site is required in G(1) to control the phosphorylation status of DNA ligase I. EMBO J (1999) 1.14
Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. J Mol Biol (1993) 1.14
Uncoupling of late transcription from DNA replication in bacteriophage T4 development. J Mol Biol (1970) 1.12
On the identity of dnaP and dnaF genes of Bacillus subtilis. Mol Gen Genet (1976) 1.12
Cowpea mosaic virus: from the presentation of antigenic peptides to the display of active biomaterials. Intervirology (2002) 1.12